IL1B and gastric cancer: The two promoter variants of IL1B, −511C>T and −31T>C SNPs, have been repeatedly associated with multiple clinical conditions [37,38] such as cardiovascular disease [39] and gastric cancer [40] as well as with clinically observed differences in the levels of IL1β protein in vivo [39,41].